First published in 2010, the EULAR recommendations for the management of RA, the most frequent inflammatory rheumatic disease, have been relied upon by healthcare professionals and organisations worldwide to offer an up-to-date and robust analysis of the effectiveness and practical use of available DMARDs – from conventional agents such as methotrexate to biologics and Janus … Read more
Prednisone is recommended as the first-line treatment for pulmonary sarcoidosis, but this steroid causes a number of unwanted side effects. Now new research published at the ATS 2025 International Conference finds that methotrexate provides a comparable alternative. Researchers found that methotrexate was as effective in controlling the disease, with potentially fewer side effects than prednisone. … Read more
Vivienne Kahlmann, MD Credit: EurekAlert.org New findings presented at the 2025 American Thoracic Society (ATS) International Conference suggest that methotrexate may be considered an effective alternative treatment to prednisone for pulmonary sarcoidosis.1,2 Although prednisone is widely considered to be the initial therapy for pulmonary sarcoidosis, its implementation is known to be commonly accompanied by different … Read more